Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion (Q27853150)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion |
scientific article |
Statements
1 reference
Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion (English)
1 reference
April 2015
0 references
35
0 references
4
0 references
2005-8
0 references